vs

Side-by-side financial comparison of bioAffinity Technologies, Inc. (BIAF) and NEXTNAV INC. (NN). Click either name above to swap in a different company.

bioAffinity Technologies, Inc. is the larger business by last-quarter revenue ($1.6M vs $945.0K, roughly 1.7× NEXTNAV INC.). bioAffinity Technologies, Inc. runs the higher net margin — -197.0% vs -7191.7%, a 6994.8% gap on every dollar of revenue. On growth, bioAffinity Technologies, Inc. posted the faster year-over-year revenue change (-27.8% vs -50.5%). bioAffinity Technologies, Inc. produced more free cash flow last quarter ($-2.6M vs $-16.1M). Over the past eight quarters, NEXTNAV INC.'s revenue compounded faster (-5.0% CAGR vs -18.6%).

bioAffinity Technologies, Inc. is a clinical-stage biotechnology firm focused on developing non-invasive in vitro diagnostic tests for early detection of cancer and respiratory diseases. It serves global healthcare markets, with a core mission to deliver accessible, high-accuracy diagnostic solutions that improve patient outcomes and reduce overall healthcare system costs.

NextNav Inc. is a specialized technology company focused on high-precision 3D geolocation and positioning solutions. Its services deliver accurate vertical location data for public safety operations, IoT use cases, mobile network management, and commercial location services, catering to enterprise and government clients across North America and select global markets.

BIAF vs NN — Head-to-Head

Bigger by revenue
BIAF
BIAF
1.7× larger
BIAF
$1.6M
$945.0K
NN
Growing faster (revenue YoY)
BIAF
BIAF
+22.7% gap
BIAF
-27.8%
-50.5%
NN
Higher net margin
BIAF
BIAF
6994.8% more per $
BIAF
-197.0%
-7191.7%
NN
More free cash flow
BIAF
BIAF
$13.5M more FCF
BIAF
$-2.6M
$-16.1M
NN
Faster 2-yr revenue CAGR
NN
NN
Annualised
NN
-5.0%
-18.6%
BIAF

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BIAF
BIAF
NN
NN
Revenue
$1.6M
$945.0K
Net Profit
$-3.1M
$-68.0M
Gross Margin
Operating Margin
-196.9%
-1706.1%
Net Margin
-197.0%
-7191.7%
Revenue YoY
-27.8%
-50.5%
Net Profit YoY
-5.7%
-110.6%
EPS (diluted)
$-3.59
$-0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIAF
BIAF
NN
NN
Q4 25
$1.6M
$945.0K
Q3 25
$1.4M
$887.0K
Q2 25
$1.3M
$1.2M
Q1 25
$1.9M
$1.5M
Q4 24
$2.2M
$1.9M
Q3 24
$2.4M
$1.6M
Q2 24
$2.4M
$1.1M
Q1 24
$2.4M
$1.0M
Net Profit
BIAF
BIAF
NN
NN
Q4 25
$-3.1M
$-68.0M
Q3 25
$-5.1M
$483.0K
Q2 25
$-4.1M
$-63.2M
Q1 25
$-2.7M
$-58.6M
Q4 24
$-3.0M
$-32.3M
Q3 24
$-2.0M
$-13.6M
Q2 24
$-2.1M
$-24.4M
Q1 24
$-2.0M
$-31.6M
Operating Margin
BIAF
BIAF
NN
NN
Q4 25
-196.9%
-1706.1%
Q3 25
-158.6%
-2239.6%
Q2 25
-198.2%
-1434.3%
Q1 25
-141.7%
-1104.9%
Q4 24
-133.5%
-772.6%
Q3 24
-84.0%
-862.0%
Q2 24
-87.1%
-1387.5%
Q1 24
-80.8%
-1544.0%
Net Margin
BIAF
BIAF
NN
NN
Q4 25
-197.0%
-7191.7%
Q3 25
-349.3%
54.5%
Q2 25
-319.9%
-5257.5%
Q1 25
-143.5%
-3806.3%
Q4 24
-134.4%
-1688.6%
Q3 24
-85.1%
-846.9%
Q2 24
-88.0%
-2207.2%
Q1 24
-81.5%
-3022.0%
EPS (diluted)
BIAF
BIAF
NN
NN
Q4 25
$-3.59
$-0.37
Q3 25
$-4.74
$-0.12
Q2 25
$-0.17
$-0.48
Q1 25
$-0.16
$-0.45
Q4 24
$-17.27
$-0.24
Q3 24
$-4.84
$-0.11
Q2 24
$-0.19
$-0.21
Q1 24
$-0.20
$-0.28

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIAF
BIAF
NN
NN
Cash + ST InvestmentsLiquidity on hand
$6.4M
$259.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$7.3M
$-86.2M
Total Assets
$11.0M
$247.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIAF
BIAF
NN
NN
Q4 25
$6.4M
$259.5M
Q3 25
$7.7M
$167.6M
Q2 25
$802.8K
$176.1M
Q1 25
$444.7K
$188.4M
Q4 24
$1.1M
$80.1M
Q3 24
$756.6K
$86.8M
Q2 24
$801.3K
$86.3M
Q1 24
$2.5M
$79.2M
Stockholders' Equity
BIAF
BIAF
NN
NN
Q4 25
$7.3M
$-86.2M
Q3 25
$8.9M
$-22.1M
Q2 25
$-2.1M
$-47.2M
Q1 25
$1.4M
$6.6M
Q4 24
$2.6M
$50.1M
Q3 24
$3.1M
$65.6M
Q2 24
$3.4M
$63.8M
Q1 24
$5.3M
$55.9M
Total Assets
BIAF
BIAF
NN
NN
Q4 25
$11.0M
$247.0M
Q3 25
$11.5M
$263.1M
Q2 25
$4.8M
$256.7M
Q1 25
$5.5M
$268.6M
Q4 24
$6.5M
$161.7M
Q3 24
$6.6M
$171.7M
Q2 24
$6.7M
$172.3M
Q1 24
$8.0M
$165.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIAF
BIAF
NN
NN
Operating Cash FlowLast quarter
$-2.6M
$-16.1M
Free Cash FlowOCF − Capex
$-2.6M
$-16.1M
FCF MarginFCF / Revenue
-160.7%
-1702.9%
Capex IntensityCapex / Revenue
0.0%
1.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-9.4M
$-50.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIAF
BIAF
NN
NN
Q4 25
$-2.6M
$-16.1M
Q3 25
$-2.5M
$-9.0M
Q2 25
$-2.6M
$-13.5M
Q1 25
$-1.6M
$-12.2M
Q4 24
$-1.7M
$-11.9M
Q3 24
$-1.7M
$-6.8M
Q2 24
$-1.5M
$-12.3M
Q1 24
$-2.3M
$-7.0M
Free Cash Flow
BIAF
BIAF
NN
NN
Q4 25
$-2.6M
$-16.1M
Q3 25
$-2.5M
$-9.0M
Q2 25
$-2.7M
$-13.6M
Q1 25
$-1.7M
$-12.2M
Q4 24
$-1.7M
$-12.1M
Q3 24
$-1.7M
$-6.8M
Q2 24
$-1.6M
$-12.4M
Q1 24
$-2.4M
$-7.0M
FCF Margin
BIAF
BIAF
NN
NN
Q4 25
-160.7%
-1702.9%
Q3 25
-171.8%
-1011.6%
Q2 25
-209.6%
-1127.4%
Q1 25
-91.3%
-793.3%
Q4 24
-76.0%
-634.0%
Q3 24
-73.1%
-422.0%
Q2 24
-65.1%
-1126.1%
Q1 24
-99.2%
-670.8%
Capex Intensity
BIAF
BIAF
NN
NN
Q4 25
0.0%
1.6%
Q3 25
0.3%
0.9%
Q2 25
1.1%
2.2%
Q1 25
2.7%
1.9%
Q4 24
0.0%
8.8%
Q3 24
0.4%
0.1%
Q2 24
1.2%
13.5%
Q1 24
1.7%
3.1%
Cash Conversion
BIAF
BIAF
NN
NN
Q4 25
Q3 25
-18.56×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons